Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3501 USD | -0.40% | +12.14% | +108.39% |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
Apr. 01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar BioLargo, Inc.
Upcoming events on BioLargo, Inc.
Past events on BioLargo, Inc.
2024-04-11 01:00 pm | OTC Markets Group Inc AI & Technology Hybrid Investor Conference |
2024-04-09 02:30 pm | LD Micro Invitational Conference |
2024-04-04 01:45 pm | Gabelli Waste & Environmental Services Symposium |
2024-04-02 05:00 pm | Q4 2023 Earnings Call |
2024-04-02 08:00 am | Q4 2023 Earnings Release |
2024-01-10 12:00 pm | Emerging Growth Conference |
2023-12-07 03:40 pm | Emerging Growth Conference |
2023-11-20 06:00 pm | Q3 2023 Earnings Call |
2023-11-19 | Q3 2023 Earnings Release After hours |
2023-10-04 | Emerging Growth Conference |
2023-10-04 01:00 pm | LD Micro Main Conference |
2023-09-28 12:45 pm | PFAS Symposium |
2023-09-13 12:00 am | Singular Research Autumn Equinox Conferece |
2023-08-16 06:00 pm | Q2 2023 Earnings Call |
2023-08-14 | Q2 2023 Earnings Release After hours |
2023-06-22 10:00 am | Singular Research Summer Solstice Conference |
2023-06-06 01:00 pm | Annual General Meeting |
2023-05-18 04:30 pm | Q1 2023 Earnings Call |
2023-05-17 10:30 am | Q1 2023 Earnings Release |
2023-04-25 11:30 am | Sequire Investor Summit |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 12,2 11,7 4.45% | 19,0 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -4,48 -4,01 -11.61% | -1,19 |
EBIT Million USD | Released Forecast Spread | 0,00 | -4,58 -4,20 -9.14% | -1,56 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | -4,47 | -3,50 -4,31 18.65% | -1,64 |
EPS USD | Released Forecast Spread | -0,02 | -0,02 -0,02 0% | -0,01 |
Announcement Date | 31/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,67 2,01 32.94% | 4,37 3,85 13.53% | 4,40 | 4,63 | 4,89 | 5,12 | |
EBITDA Million USD | Released Forecast Spread | -1,49 -1,28 -16.36% | -1,00 -0,55 -81.5% | -0,45 | -0,35 | -0,24 | -0,14 | |
EBIT Million USD | Released Forecast Spread | -1,54 -1,35 -13.94% | -1,01 -0,62 -61.35% | -0,54 | -0,44 | -0,34 | -0,25 | |
Net income Million USD | Released Forecast Spread | -1,20 -1,39 13.52% | -0,73 -0,66 -10.09% | -0,56 | -0,46 | -0,36 | -0,27 | |
EPS USD | Released Forecast Spread | -0,01 0,00 - | -0,01 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Announcement Date | 14/11/23 | 01/04/24 | - | - | - | - | - |
Past sector events for BioLargo, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLGO Stock
- Calendar BioLargo, Inc.